More on RGLS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.38 |
|
|||
| Open | $1.37 | ||||
| 52 Wk High | $10.60 | ||||
| 52 Wk Low | $2.13 | ||||
| Day High | $1.56 | ||||
| Day Low | $1.35 | ||||
| P/E | 0.04 | ||||
| EPS | $38.45 | ||||
| Volume | 245,391 | ||||
- H.C. Wainwright Reiterates Buy Rating on Regulus Therapeutics (RGLS)
- Form 10-K Regulus Therapeutics For: Dec 31
- Form 8-K Regulus Therapeutics For: Mar 13
- Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates
- Form 8-K Regulus Therapeutics For: Feb 28
- Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference
- Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
- Form 4 Regulus Therapeutics For: Jan 30 Filed by: Hagan Joseph P
- Form 4 Regulus Therapeutics For: Jan 30 Filed by: Klassen Preston
- Form 4 Regulus Therapeutics For: Jan 30 Filed by: Aker Christopher Ray
Entities mentioned with RGLS
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Needham & Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Pre Market Movers | View Related Stories »
- Pre-Open Losers | View Related Stories »
- Show More...
